Stryker, OrthoSensor renew knee replacement co-marketing agreement

Stryker ($SYK) and OrthoSensor extended their agreement to co-market Stryker's Triathlon knee system and OrthoSensor's Verasense feedback software for knee-replacement surgery. Verasense offers data to surgeons on soft-tissue balance during the surgery, allowing Triathlon to perform better later on. OrthoSensor, which now has $36 million worth of Series B funding for its knee-balancing software, struck the original deal with Stryker last August, and the FDA-approved Verasense is, as a result, only compatible with the Triathlon device. Release

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.